Cannabis Report
Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

ARYC Potential revenue streams partial list:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BZstocks Member Profile
Member Level 
Followed By 78
Posts 4,495
Boards Moderated 1
Alias Born 02/02/12
160x600 placeholder
BZstocks Member Level  Saturday, 02/10/18 09:00:26 PM
Re: None
Post # of 94389 

ARYC Potential revenue streams partial list:
List compiled from recent company tweets -

1. USDA:
a. Arrayit-USDA food safety test readily detects Listeria monocytogenes implicated in recent food contamination recall…
b. Arrayit-USDA miniaturized and multiplexed food safety test can rapidly identify pathogens and increase food safety…
c. Arrayit-USDA microarray technology food safety test Sensors manuscript published in Google Scholar database…
d. Arrayit reports $228,000 microarray technology and services lead from top United States Department Agriculture USDA
f. 1-9-18:Arrayit-USDA food safety team receives speaking invitation to the top international science meeting entitled the 22nd International Conference on Food Processing and Analysis to be held on October 11-13 2018 in Moscow Russia

2. DOD:
a. Arrayit provides additional samples for $2.9 million microarray tech sale to United States Department of Defense DOD.

3. Micro array services:
a. Arrayit signs $27.1 million term sheet for microarray services with US-based research leader
b. Arrayit microarray services team completes pilot project for top investigator at the world renowned cancer center Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology MIT in Cambridge Massachusetts USA
c. From 1-3-18: Arrayit microarray services team quotes $2,500,000 research sale to top proteomics research laboratory headquartered in the Northeastern USA

4. Micro array platforms:
a. Arrayit completes site visit with major European life sciences leader regarding sale of 40 microarray platforms…

b. Arrayit patented and proprietary microarray platform featuring miniaturization, parallelism and automation is well-suited for Global In Vitro Diagnostic Market Boom including in vitro diagnostic IVD tests per top analysts Zacks…
c. Arrayit microarray technology customers include 8 of the world's top 10 pharmaceutical companies with a combined market cap exceeding $1.4 trillion…
d. Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception
e. Arrayit proprietary DNA microarray platform well-positioned in the gene expression market which, according to business research leaders MarketsandMarkets™, is expected to reach $5.3 billion by 2020

5.Diabetes testing: Arrayit microarray services team accelerates biomarker discovery for growing $32 billion diabetes testing market
b. 1-31-18: Arrayit clinical and microarray services teams reports positive project update from top diabetes research and companion diagnostic testing development leader headquartered in the Southern USA

6. Parkinsons Disease Test: 1-7-18: Arrayit patented and proprietary microarray-based biomarker discovery program and PDx™ Parkinsons Disease Companion Diagnostic Test can greatly reduce the cost of PD drug discovery by pinpointing molecular pathways in advance of costly clinical trials

7. ARMY:

a. Arrayit reports prostate cancer test sourcing request from United States Army Medical Center Bethesda Maryland

b. Arrayit reports $1,745,000 microarray services inquiry from top government agency United States Army Medical Center
c. Arrayit reports $84,000 microarray platform sale to http://US.Army ;
Medical Research USAMRIID Frederick MD

8. National Institutes of Health: Arrayit submits capabilities statement for major microarray services contract with National Institutes of Health NIH

9. Veterinary diagnostics market: Arrayit reports positive steps towards entering the rapidly growing $6.7 billion veterinary diagnostics market with companion animal wellness tests that leverage our patented and proprietary microarray technology

10. B2B partners:

a. 1-19-18: Arrayit business development team reports business-to-business B2B opportunity with healthcare leader GE Healthcare Life Sciences a subsidiary of $141.7 billion world industrial and technology leader General Electric NYSE:GE

b. Arrayit business-to-business B2B partner Sensovation Radolfzell Germany introduces new SensoSpot® Microarray Analyzers for multiplex-enabled imaging and automated microarray analysis

c. 1-25-18: Arrayit schedules business-to-business B2B site visit today with a large microarray services account headquartered in the Eastern USA
d. Arrayit reports business-to-business B2B expansion opportunity with medical manufacturing leader Anjue Medical China
e. Arrayit reports successful business expansion conference call with world antibody production leader Abnova Taiwan
f. Arrayit reports business expansion opportunity with leading wellness research center headquartered in Cleveland OH…
g. Arrayit business development team reports business-to-business growth opportunity with platform technology leaders Ionica Sciences headquartered at Cornell University in Ithaca New York USA
h. Arrayit business development team receives BioPark speed to market and facilities expansion invitation from world healthcare leader GE Healthcare a subsidiary of $151.2 billion General Electric NYSE:GE
i. 2-7-18: Arrayit business development team reports business-to-business B2B opportunity with top personal genomics leaders HumanCode combining digital and mobile health with genomics for improved wellness
j. 2-9-18: Arrayit bioinformatics team reports business-to-business B2B opportunity with top business software search leaders Crozdesk headquartered in London United Kingdom and specializing in advanced software discovery

11. FDA:
a. Arrayit reports $155,000 microarray platform RFQ from the United States Food and Drug Administration FDA
b. 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance

12. TELECHEM international is a subsidiary of Arrayit:

a. 12-22-17: Arrayit chemical trading subsidiary TeleChem International Inc reports $8,100 speciality chemical sale to a top industrial supplier headquartered in Arlington Texas
b. 1-23-18: Arrayit chemical trading subsidiary TeleChem International reports chemical synthesis inquiry from the National Center for Advancing Translational Sciences NCATS National Institutes of Health NIH for diagnostic and therapeutic methods and technologies
c. 2-2-18: Arrayit chemical trading subsidiary TeleChem International reports $25,000 specialty chemical sale to a top high-end specialty chemical company headquartered in the Western United States and focusing on advanced environmental remediation technology

13. Avant Diagnostics, Inc.: ARYC also owns 40 million shares of AVDX.



15. New Products. Arrayit's ArrayIt® SuperEpoxy Microarray Substrates provide the highest quality glass microarray printing substrate at an affordable price. All of our substrates are manufactured in state-of-the art class 10 cleanrooms, with 0.1 µm filtered air, and temperature and humidity control. Cleanroom manufacture eliminates contamination of the microarray surface with particulates, proteases, nucleases and other contaminants that impair the quality of microarray experimentation. Compare our SuperEpoxy Substrates to traditional microarray slides and you will see the difference.

16. 1-3-18 Arrayit advanced microarray technology to be incorporated into a clinical trial by a major pharmaceutical giant in a development that could significantly increase revenues and earnings in 2018

17. Other including additional distributorship opportunities:

a. 1-26-18: Arrayit government contracts team prepares molecular testing bid for the Department of Veteran Affairs Network Contracting Office NCO at the GV Sonny Montgomery VA Medical Center headquartered in Jackson Mississippi USA

b. 1-9-18: Arrayit business development team reports revenue expansion opportunity with small molecule target identification leaders Shantani Proteome Analytics headquartered in Maharashtra India

c. Arrayit reports positive feedback regarding commercialization opportunity from Columbia Technology Ventures New York

d. Arrayit reports microarray tech expansion opportunity with largest and strongest eCommerce platform in Japan i-order
e. Arrayit quotes $348,000 annual supply agreement to top wellness testing leader Medica Laboratories Bangkok Thailand
f. Arrayit reports $350,000 microarray services inquiry from leading Veterans Administration Health Care Palo Alto CA
g. Arrayit clinical team completes site visit with clinical experts from a prestigious Northern California hospital and a major governmental approval agency
h. 12-19-17: Arrayit sales and marketing team reports distributorship request from life sciences leaders Elettrofor headquartered in Borsea Italy specializing in research and laboratory instruments and reagents
i. Arrayit new 12/28/2017 company newsletter features our popular SuperEpoxy 2 Microarray Substrate Slide product line which facilitates a wide spectrum of microarray applications including DNA, protein, antigen, antibody, RPPA and whole cell applications
j. 1-26-18: Arrayit reports new distributorship and price list request from diagnostic and laboratory research leaders Molgen Biotechnology Lab Supplies headquartered in Istanbul Turkey and specializing in PCR, ELISA, immunohistochemistry, antibodies and consumables
k. 1-29-18: Arrayit business development team reports revenue expansion opportunity with top Korean government trade promotion organization Kotra with US offices in Los Angeles and Torrance California USA
l. 2-9-18: Arrayit sales and marketing team reports new distributor request from life sciences distribution leaders Biosystems headquartered in Sofia Bulgaria and specializing in biochemistry, clinical chemistry and molecular biology
m. 2-7-18: Arrayit sales and marketing team reports global distribution opportunity with marketshare and branding leaders NPI headquartered in Boca Raton Florida USA and operating in the $153 billion health and wellness sector

ALL i say is my opinion only.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist